Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology Drug Discovery. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of substituted indolinones targeting CDK complexes. Offers streamlined routes for high-purity pharmaceutical intermediates and cost-effective API manufacturing.
Discover high-purity pyrimido[1,2,4]-triazole hydrazine compounds for anticancer drug development. Our patented synthesis offers cost reduction in pharmaceutical intermediate manufacturing.
Novel Rh-catalyzed one-pot route for spiro-oxindoles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for oncology drug development.
Discover novel chromone compounds with antitumor activity. Our advanced PPA cyclization process ensures high purity and scalable supply for pharmaceutical manufacturing.
Patent CN109776384B reveals a one-step Rh-catalyzed synthesis of complex bis-quaternary carbon oxindoles, offering significant cost reduction in API manufacturing and high atom economy.
Patent CN112979662A details a transition-metal-free acetoxylation route. This breakthrough offers cost reduction in pharmaceutical intermediate manufacturing with high purity.
Discover novel pyrimidine derivatives via Suzuki coupling. Enhance your pipeline with high-purity intermediates and cost-effective manufacturing solutions.
Patent CN111592487B reveals potent dual-target anticancer agents. Efficient synthesis offers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113214255A details a scalable four-step synthesis of 2,6-diazaspiro[3.5]nonane intermediates, offering cost-effective routes for pharmaceutical manufacturing.
Novel solid-phase method for EGFR inhibitors. High purity, scalable route for anticancer drug discovery intermediates.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Patent CN107879989B details a robust synthetic route for bioactive benzodiazepines with antitumor activity, offering scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.